Holen Sie sich die Stockscreener-App
5.0858
1.83%
-0.0942
Schlusskurs vom Vortag:
$5.18
Offen:
$5.18
24-Stunden-Volumen:
359.82K
Relative Volume:
0.25
Marktkapitalisierung:
$645.35M
Einnahmen:
$433.14M
Nettoeinkommen (Verlust:
$4.95M
KGV:
142.46
EPS:
0.0357
Netto-Cashflow:
$6.55M
1W Leistung:
-5.65%
1M Leistung:
+19.65%
6M Leistung:
+85.59%
1J Leistung:
+31.40%
1-Tages-Spanne:
$5.045
$5.21
1-Wochen-Bereich:
$5.045
$5.57
52-Wochen-Spanne:
$2.6101
$7.0771
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Firmenname
Organogenesis Holdings Inc
Sektor
Telefon
781-575-0775
Adresse
85 DAN ROAD, CANTON, MA
Vergleichen Sie ORGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
5.085 | 657.40M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
128.84 | 56.49B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.47 | 45.56B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.835 | 43.55B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.62 | 30.85B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
479.75 | 20.93B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Lake Street | Buy |
| 2024-02-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-06-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-05-24 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-11-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
| 2019-04-17 | Eingeleitet | Oppenheimer | Outperform |
| 2019-04-11 | Eingeleitet | SunTrust | Buy |
Alle ansehen
Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten
Have Organogenesis Holdings Insiders Been Selling Stock? - simplywall.st
Organogenesis Holdings Insider Sold Shares Worth $1,592,120, According to a Recent SEC Filing - MarketScreener
Organogenesis director Nussdorf sells $1.59 million in shares By Investing.com - Investing.com Australia
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Shares Bounce 27% But Its Business Still Trails The Industry - simplywall.st
Organogenesis director Nussdorf sells $1.59 million in shares - Investing.com
Dir Nussdorf Sells 300,000 ($1.6M) Of Organogenesis Holdings Inc [ORGO] - TradingView
Dir Nussdorf Files To Sell 200,000 Of Organogenesis Holdings Inc [ORGO] - TradingView
Dir Nussdorf Files To Sell 100,000 Of Organogenesis Holdings Inc [ORGO] - TradingView
Organogenesis (NASDAQ:ORGO) Price Target Raised to $9.00 - Defense World
Organogenesis Holdings (NASDAQ:ORGO) pulls back 8.4% this week, but still delivers shareholders solid 26% CAGR over 3 years - Yahoo Finance
Organogenesis Holdings (NASDAQ:ORGO) pulls back 8.4% this week, but still delivers shareholders splendid 26% CAGR over 3 years - simplywall.st
Organogenesis (NASDAQ:ORGO) Trading Up 6.2% After Analyst Upgrade - Defense World
Organogenesis Holdings Inc.Class A (NQ: ORGO - Markets Financial Content
Is Organogenesis Holdings Inc. (2PQ) stock supported by strong fundamentalsPortfolio Profit Report & Weekly Stock Performance Updates - newser.com
Organogenesis stock price target raised to $9 by BTIG on reimbursement changes - Investing.com South Africa
Global Wound Healing Devices Market Poised for Robust Growth at a CAGR of ~5% by 2032, Driven by Rising Chronic Wound Burden | DelveInsight - GlobeNewswire Inc.
What makes Organogenesis Holdings Inc. (2PQ) stock appealing to growth investorsMarket Volume Summary & Fast Exit and Entry Strategy Plans - newser.com
Can Organogenesis Holdings Inc. stock surprise with earnings upsideJuly 2025 Closing Moves & High Accuracy Trade Alerts - newser.com
Will Organogenesis Holdings Inc. stock attract more institutional investorsQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
How dovish Fed policy supports Organogenesis Holdings Inc. (2PQ) stock2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock supported by free cash flowWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com
Will Organogenesis Holdings Inc. stock maintain dividend yieldPortfolio Risk Summary & Low Risk Entry Point Tips - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock at risk of policy regulationWeekly Stock Summary & AI Powered Market Entry Ideas - newser.com
Is Organogenesis Holdings Inc. stock positioned for digital transformation2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com
Can Organogenesis Holdings Inc. rally from current levelsGold Moves & Safe Entry Zone Tips - newser.com
Using Python tools to backtest Organogenesis Holdings Inc. strategies2025 Performance Recap & Real-Time Volume Analysis - newser.com
Detecting price anomalies in Organogenesis Holdings Inc. with AIDollar Strength & Safe Swing Trade Setup Alerts - newser.com
Is Organogenesis Holdings Inc. showing signs of accumulationJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Exit strategy if you’re trapped in Organogenesis Holdings Inc.Earnings Growth Summary & Accurate Entry/Exit Alerts - newser.com
How Organogenesis Holdings Inc. (2PQ) stock benefits from digital adoptionEarnings Trend Report & Daily Technical Forecast Reports - newser.com
The growth track for Organogenesis Holdings Inc (ORGO) has changed recently - Setenews
Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Organogenesis Holdings Inc-Aktie (ORGO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| NUSSDORF GLENN H | Director |
Nov 24 '25 |
Sale |
5.34 |
100,000 |
534,000 |
2,965,591 |
| NUSSDORF GLENN H | Director |
Nov 25 '25 |
Sale |
5.30 |
12,043 |
63,828 |
2,953,548 |
2.95%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):